Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Biogen describes new OGA inhibitors

April 8, 2020

Phase IIa study of golexanolone shows no clinical benefit

April 8, 2020

Stopping tau in its tracks

April 8, 2020

Minimal phenotyping gives minimal insights into MDD genetics

April 8, 2020

Ono Pharmaceutical divulges PTGDR2 antagonists

April 7, 2020

AXS-07 achieves both coprimary endpoints in INTERCEPT phase III study

April 7, 2020

Glycoprotein negatively regulates adult neurogenesis

April 7, 2020

Optogenetic plaque model traces neurodegeneration in AD

April 6, 2020

Discovery and preclinical evaluation of an oral nicotinic acetylcholine alpha7 receptor PAM

April 6, 2020

X, Y copies of neuroligin-4 have different functions

April 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...